EFFECT OF AGE ON IBUPROFEN PHARMACOKINETICS AND ANTIPYRETIC RESPONSE

被引:50
作者
KAUFFMAN, RE
NELSON, MV
机构
[1] WAYNE STATE UNIV, DEPT PEDIAT, DIV CLIN PHARMACOL & TOXICOL, DETROIT, MI 48202 USA
[2] WAYNE STATE UNIV, DEPT PHARMACOL, DETROIT, MI 48202 USA
关键词
D O I
10.1016/S0022-3476(05)80354-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The effect of age on ibuprofen pharmacokinetics and antipyretic effect was studied in 49 infants and children aged 3 months to 10.4 years. The relationship of plasma concentration to antipyretic effect was examined in 38 of the children by using an iterative least squares technique that allows estimation of drug concentration with time in a theoretical effect compartment and rate constant for elimination of drug from the effect compartment. There was a delay of 1 to 3 hours between peak ibuprofen plasma concentration and peak temperature decrement. The mean elimination rate constant from the effect compartment was 0.6 hour-1, corresponding to a half-life of drug in the effect compartment of 1.1 hours. The mean slope of the effect compartment concentration versus temperature regression line was -0.242-degrees-C/mg per liter. Age did not significantly influence the rate of absorption of ibuprofen, its plasma concentration, its rate of elimination, or the time course of ibuprofen concentration in the effect compartment. However, in younger children the onset of antipyresis was earlier, maximum antipyretic effect was greater, and the area under the curve of the percentage of change in temperature from baseline versus time was greater than in older children. We conclude that the greater relative body surface area in younger children may allow more efficient dissipation of heat in response to antipyretic-induced lowering of the temperature "set point" in the hypothalamus.
引用
收藏
页码:969 / 973
页数:5
相关论文
共 17 条
[1]   PHARMACOLOGICAL DIFFERENCES BETWEEN OPTICAL ISOMERS OF IBUPROFEN - EVIDENCE FOR METABOLIC INVERSION OF (-)-ISOMER [J].
ADAMS, SS ;
BRESLOFF, P ;
MASON, CG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (03) :256-257
[2]  
Akaike H., 1976, MATH SCI, V14, P5
[3]   DETERMINATION OF IBUPROFEN BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ARAVIND, MK ;
MICELI, JN ;
KAUFFMAN, RE .
JOURNAL OF CHROMATOGRAPHY, 1984, 308 (JUN) :350-353
[4]  
BENVENUTI C, 1986, INT J CLIN PHARM TH, V24, P308
[5]  
BROWN DR, 1992, J CLIN PHARMACOL, V32, P231
[6]   MECHANISMS OF ANTI-PYRETIC ACTION [J].
CLARK, WG .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1979, 10 (02) :71-77
[7]  
DINARELLO CA, 1978, NEW ENGL J MED, V298, P607, DOI 10.1056/NEJM197803162981107
[8]   SIMULTANEOUS MODELING OF PHARMACOKINETICS AND PHARMACODYNAMICS WITH A NONPARAMETRIC PHARMACODYNAMIC MODEL [J].
FUSEAU, E ;
SHEINER, LB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) :733-741
[9]   UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].
HOLFORD, NHG ;
SHEINER, LB .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453
[10]   ANTIPYRETIC EFFICACY OF IBUPROFEN VS ACETAMINOPHEN [J].
KAUFFMAN, RE ;
SAWYER, LA ;
SCHEINBAUM, ML .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1992, 146 (05) :622-625